Former Lilly exec confirmed as U.S. Health & Human Services secretary | January 29, 2018 Issue - Vol. 96 Issue 5 | Chemical & Engineering News
Volume 96 Issue 5 | p. 17 | Concentrates
Issue Date: January 29, 2018

Former Lilly exec confirmed as U.S. Health & Human Services secretary

Department: Government & Policy
Keywords: Pharmaceuticals, Drug safety, FDA, CDC, NIH, HHS, Azar, Trump
[+]Enlarge
Azar speaks during his Senate confirmation hearing on Jan. 9.
Credit: Tom Williams/CQ Roll Call/Newscom
Photo of Alex Azar.
 
Azar speaks during his Senate confirmation hearing on Jan. 9.
Credit: Tom Williams/CQ Roll Call/Newscom

Alex Azar, President Donald J. Trump’s nominee to head the U.S. Department of Health & Human Services (HHS), was confirmed by the Senate on Jan. 24. Azar is the former president of Lilly USA, the parent company of pharmaceutical giant Eli Lilly & Co., where he worked for 10 years before being nominated by Trump. HHS oversees most of the nation’s health care industry, including Medicare and the insurance program known as Obamacare. It also is the parent agency for the Food & Drug Administration, the Centers for Disease Control & Prevention, and the National Institutes of Health. Azar doesn’t have a science background—he is a lawyer with an undergraduate degree in economics and government. In his confirmation hearing, Azar said that drug prices are too high and he would explore whether the government should be able to negotiate lower fees. He previously served in HHS during the George W. Bush administration as deputy director and general counsel. Azar replaces Tom Price, Trump’s first appointee to the HHS position, who resigned in September 2017 over criticism of his use of private jets for government travel.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment